Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Shares Outstanding (2016 - 2025)

Dare Bioscience (DARE) has disclosed Shares Outstanding for 8 consecutive years, with $86.6 million as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Shares Outstanding rose 2.14% year-over-year to $86.6 million, compared with a TTM value of $86.6 million through Jun 2023, up 2.14%, and an annual FY2022 reading of $84.8 million, up 1.05% over the prior year.
  • Shares Outstanding was $86.6 million for Q2 2023 at Dare Bioscience, up from $86.2 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $86.6 million in Q2 2023 and bottomed at $24.7 million in Q1 2020.
  • Average Shares Outstanding over 4 years is $64.6 million, with a median of $80.3 million recorded in 2021.
  • The sharpest move saw Shares Outstanding soared 127.96% in 2021, then grew 1.05% in 2022.
  • Year by year, Shares Outstanding stood at $41.6 million in 2020, then soared by 101.81% to $83.9 million in 2021, then grew by 1.05% to $84.8 million in 2022, then increased by 2.13% to $86.6 million in 2023.
  • Business Quant data shows Shares Outstanding for DARE at $86.6 million in Q2 2023, $86.2 million in Q1 2023, and $84.8 million in Q4 2022.